This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_EYE_ADNEXA_EXALLC for full statistics.
Malignant neoplasm of eye and adnexa
C3_EYE_ADNEXA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
287 |
4. Check minimum number of eventsNone |
287 |
5. Include endpointsNone |
287 |
6. Filter based on genotype QC (FinnGen only) |
287 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of eye and adnexa
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of eye, brain and central nervous system
- Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 287 | 133 | 154 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.07 |
| Median age at first event (years) | 60.01 | 58.25 | 61.53 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 259
- Matched controls
- 2589
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
2699.6
153.2
133
*
CKE60
NOMESCO Finland
Brachytherapy of choroid and retina
2176.3
134.9
119
*
CKE65
NOMESCO Finland
Removal of brachytherapeutic plate from eye
2176.3
134.9
119
*
XCD10
NOMESCO Finland
Electrophysiological examination of eye
104.9
119.8
126
23
C69.32
ICD-10 Finland
Malignant tumor of the chorioidea melanoma
1803.5
119.7
107
*
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
336.8
75.7
73
*
WX140
NOMESCO Finland
Parabulbar anesthesy
28.3
72.0
101
57
C69.3
ICD-10 Finland
Malignant neoplasm: Choroid
+∞
71.2
65
*
XCK10
NOMESCO Finland
Photography of fundus of eye
15.6
70.7
131
159
8720/3-C69.9
ICD-O-3
Malignant melanoma, NOS, of eye, NOS
+∞
70.0
64
*
8720/3-C69.3
ICD-O-3
Malignant melanoma, NOS, of choroid
+∞
67.7
62
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
12.8
47.3
91
105
C69.39
ICD-10 Finland
Malignant tumor in chorioidea other or unspecified histology
+∞
37.4
35
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
9.4
36.2
82
122
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
91.1
35.9
39
5
WX002
NOMESCO Finland
Sedation and analgesia
6.2
35.4
117
302
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
30.1
32.2
43
17
XCW99
NOMESCO Finland
Other investigative procedure of eye
7.3
32.0
86
164
CFA20
NOMESCO Finland
Biopsy of conjunctiva
168.9
29.3
30
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
168.9
29.3
30
*
C69.02
ICD-10 Finland
Malignant tumor in conjunctival melanoma
+∞
28.7
27
*
9510/3-C69.2
ICD-O-3
Retinoblastoma, NOS, of retina
+∞
27.6
26
*
ZXA05
NOMESCO Finland
Left side
4.4
26.3
130
482
Z01.0
ICD-10 Finland
Examination of eyes and vision
5.2
25.2
91
243
CAA30
NOMESCO Finland
Biopsy of orbit
275.5
25.1
25
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
8.1
23.3
55
83
CF2S4
NOMESCO Finland
Photography of conjunctiva
+∞
23.3
22
*
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
251.3
23.0
23
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
26.9
22.8
31
13
ZXA00
NOMESCO Finland
Right side
3.8
21.5
122
489
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
27.0
21.4
29
12
1906B
ICD-9 Finland
Malignant neoplasm of eye, Choroid[MELANOMA CHORIOIDEAE]
+∞
21.1
20
*
S01ED51
ATC
timolol, combinations; ophthalmic
5.8
18.0
54
112
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
102.2
17.8
19
*
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
53.9
17.2
20
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
3.1
17.1
141
713
C69.21
ICD-10 Finland
Retina
+∞
16.8
16
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
29.9
16.8
22
8
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
181.2
16.7
17
*
130
Kela drug reimbursment
Malignant tumour
5.2
16.6
55
128
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
12.0
16.5
30
28
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
28.4
15.9
21
8
8000/3-C69.3
ICD-O-3
Neoplasm, malignant of choroid
+∞
15.8
15
*
C69.40
ICD-10 Finland
Malignant tumor of ciliary body without histology
+∞
15.8
15
*
9699/3-C69.6
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of orbit, NOS
+∞
15.8
15
*
3770
FHL
Placing a radiating plate on the surface of the eye with additional measures
+∞
15.8
15
*
Z51.5
ICD-10 Finland
Palliative care
6.5
15.3
41
73
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
6.2
14.9
41
76
C69.42
ICD-10 Finland
Malignant tumor of ciliary melanoma
+∞
14.7
14
*
3779
FHL
Other operations in this group include disc removal
+∞
14.7
14
*
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
158.6
14.6
15
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.8
14.1
126
646
WF002
NOMESCO Finland
Radical radiotherapy
6.8
13.8
35
58
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
79.4
13.7
15
*
CDC00
NOMESCO Finland
Enucleation of eye
+∞
13.7
13
*
CDC10
NOMESCO Finland
Enucleation of eye with insertion of prosthesis
147.4
13.6
14
*
H26.2
ICD-10 Finland
Complicated cataract
27.5
13.6
18
7
XW000
NOMESCO Finland
Bone marrow biopsy
7.7
13.3
31
45
A03FA01
ATC
metoclopramide; systemic, rectal
3.1
12.8
81
327
L01AX03
ATC
temozolomide; systemic
33.9
12.7
16
5
CD2S4
NOMESCO Finland
Photography of eye
73.6
12.7
14
*
C69.20
ICD-10 Finland
Retina
+∞
12.6
12
*
C69.09
ICD-10 Finland
Malignant tumor in conjunctival other or unspecified histology
+∞
12.6
12
*
CBA10
NOMESCO Finland
Biopsy of eyelid
22.6
12.2
17
8
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.9
12.0
34
65
WX142
NOMESCO Finland
Sub-tenon anesthesy
49.1
12.0
14
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
12.6
11.5
20
17
C69.99
ICD-10 Finland
Malignant tumor in unspecified localization in eye or other unspecified histology
+∞
11.5
11
*
9699/3-C69.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of conjunctiva
+∞
11.5
11
*
Z97.0
ICD-10 Finland
Presence of artificial eye
+∞
11.5
11
*
C69.03
ICD-10 Finland
Malignant tumor of conjunctival carcinoma
+∞
11.5
11
*
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
125.4
11.5
12
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
12.7
11.0
19
16
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.6
10.9
104
531
H02AB02
ATC
dexamethasone; systemic
3.9
10.8
46
135
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
62.6
10.7
12
*
JN4BD
NOMESCO Finland
Extensive body CT
3.5
10.6
53
178
XX7GT
NOMESCO Finland
Selective internal radio therapy (SIRT) with Yttrium
+∞
10.5
10
*
CH2S4
NOMESCO Finland
Photography of iris
+∞
10.5
10
*
C69.60
ICD-10 Finland
Malignant tumor in orbit without histology
+∞
10.5
10
*
180
Kela drug reimbursment
Interferon alfa
27.2
9.9
13
5
S01ED01
ATC
timolol; ophthalmic
5.6
9.7
28
55
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.8
9.7
27
51
A04AA02
ATC
granisetron; systemic, transdermal
4.8
9.6
32
74
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
7.4
9.5
22
32
JN6AD
NOMESCO Finland
CT of torso and neck
22.7
9.4
13
6
H05.2
ICD-10 Finland
Exophthalmic conditions
+∞
9.4
9
*
8720/3-C69.0
ICD-O-3
Malignant melanoma, NOS, of conjunctiva
+∞
9.4
9
*
C69.29
ICD-10 Finland
Retina
+∞
9.4
9
*
N02AA05
ATC
oxycodone; systemic
2.9
9.3
63
260
JN4CD
NOMESCO Finland
Very extensive body CT
6.3
9.3
24
41
CA1ME
NOMESCO Finland
Ultrasound oculometry
16.3
9.1
14
9
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.0
9.0
36
100
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
51.8
8.7
10
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
4.5
8.6
30
73
ZX070
NOMESCO Finland
Intensity modified radiotherapy
11.3
8.4
15
14
C69.63
ICD-10 Finland
Malignant tumor of orbital carcinoma
+∞
8.4
8
*
1905A
ICD-9 Finland
Malignant neoplasm of eye, Retina[RETINOBLASTOMA RETINAE]
+∞
8.4
8
*
19003
ICD-8 Finland
Malignant neoplasm of eye, Retinae
+∞
8.4
8
*
CAW99
NOMESCO Finland
Other operation on orbit
+∞
8.4
8
*
C69.2
ICD-10 Finland
Malignant neoplasm: Retina
+∞
8.4
8
*
XCD20
NOMESCO Finland
Photoangiography of eye
10.5
8.1
15
15
A06AH03
ATC
naloxegol; oral
34.5
8.1
10
*
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
22.9
8.1
11
5
ZXA10
NOMESCO Finland
Bilateral
2.5
8.0
68
320
C82.1
ICD-10 Finland
Follicular lymphoma grade II
46.4
7.8
9
*
H33.0
ICD-10 Finland
Retinal detachment with retinal break
6.8
7.6
18
28
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
7.5
130
842
A04AA01
ATC
ondansetron; systemic, rectal
3.8
7.5
31
89
9591/3-C69.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of eye, NOS
+∞
7.3
7
*
C69.45
ICD-10 Finland
Melanoma of iris
+∞
7.3
7
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
7.3
7
*
CAD00
NOMESCO Finland
Exenteration of orbit with use of graft or flap
+∞
7.3
7
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
6.2
7.1
18
31
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
17.2
6.8
10
6
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
6.2
6.7
17
29
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.0
6.6
17
30
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
5.3
6.3
18
36
C69.91
ICD-10 Finland
Malignant tumor in unspecified localization in the eye retinoblastoma
+∞
6.3
6
*
C69.90
ICD-10 Finland
Malignant tumor in unspecified localization in eye without histology
+∞
6.3
6
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
27.4
6.3
8
*
L03AB05
ATC
interferon alfa-2b; parenteral
27.4
6.3
8
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
8.0
6.2
13
17
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
6.2
83
477
L03AA13
ATC
pegfilgrastim; parenteral
5.4
6.1
17
33
H43.1
ICD-10 Finland
Vitreous haemorrhage
6.3
6.1
15
25
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.0
6.1
23
62
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.4
6.0
52
244
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
76
197
4.89
28.21
1.8
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
159
731
3.63
25.88
5.7
3.2
u/l
32.5
34.0
0.23
152
701
(40768441) Liver Pathology biopsy report
23
21
11.82
21.82
1.2
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
62
229
3.18
13.20
1.4
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
58
211
3.19
12.63
1.4
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
17
23
7.79
11.97
1.4
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
42
137
3.42
10.84
1.3
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
130
756
2.32
10.82
8.9
5.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
18
30
6.33
10.52
1.5
1.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
183
1240
2.31
10.42
11.5
6.4
umol/l
13.6
11.6
0.74
178
1171
(3013650) Neutrophils [#/volume] in Blood by Automated count
188
1305
2.28
9.87
16.7
9.2
e9/l
3.8
4.2
1.72
170
1143
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
229
1776
2.43
8.56
14.7
7.5
u/l
91.6
82.1
1.36
217
1651
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
8
0
+∞
8.37
1.3
0.0
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
153
1021
2.07
8.34
6.2
4.7
g/l
34.6
35.1
0.45
145
954
(3045142) Bone marrow Pathology biopsy report
16
31
5.41
8.02
1.4
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
33
115
3.11
7.61
1.8
2.7
u/ml
19.4
168.1
1.26
27
95
(40768804) Tissue Pathology biopsy report
133
888
1.93
6.82
2.6
2.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
12
21
5.92
6.64
1.3
2.2
e6/l
954.4
596.4
—
5
8
(40758558) Short blood count panel - Blood
95
571
1.99
6.59
12.7
7.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
165
1197
1.89
6.44
8.4
7.0
mmol/l
1.2
1.2
0.22
139
993
(3001604) Monocytes [#/volume] in Blood
158
1132
1.88
6.39
9.6
5.5
e9/l
0.6
0.6
0.05
142
976
(3013115) Eosinophils [#/volume] in Blood
162
1171
1.88
6.36
10.1
5.7
e9/l
0.2
0.2
0.76
147
1030
(46235355) HIV 1 and 2 tests - Meaningful Use set
53
258
2.29
6.32
1.4
1.6
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
6
0
+∞
6.27
1.3
0.0
%
36.0
—
—
6
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
6
0
+∞
6.27
1.3
0.0
%
22.3
—
—
6
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
6
0
+∞
6.27
1.0
0.0
%
9.0
—
—
6
0
(3006315) Basophils [#/volume] in Blood
158
1137
1.87
6.26
9.6
5.6
e9/l
0.0
0.0
0.02
142
982
(3019198) Lymphocytes [#/volume] in Blood
159
1156
1.84
6.00
9.7
5.6
e9/l
2.4
1.9
0.49
145
1017
(3023368) Bacteria identified in Blood by Culture
106
689
1.85
5.67
3.4
4.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
51
261
2.16
5.36
2.3
4.1
ug/l
3.3
31.6
0.58
35
221
(3051671) S100 calcium binding protein B [Mass/volume] in Serum
5
0
+∞
5.22
2.4
0.0
ug/l
0.1
—
—
5
0
(3035637) Corticotropin [Mass/volume] in Plasma
13
31
4.35
5.14
1.9
1.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
147
1076
1.75
5.14
9.7
5.7
%
56.1
57.5
0.72
142
1004
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
17
50
3.55
5.11
1.3
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
148
1087
1.75
5.10
7.3
6.4
mmol/l
1.2
1.2
0.12
141
978
(3015377) Calcium [Moles/volume] in Serum or Plasma
113
772
1.76
5.00
6.8
3.1
mmol/l
2.4
2.4
0.29
101
675
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
43
3.63
4.68
3.6
3.6
%
52.7
58.3
0.51
15
43
(3044640) Blood type and Crossmatch panel - Blood
105
718
1.73
4.55
3.1
2.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
11
26
4.36
4.39
1.7
2.1
e9/l
1.2
0.7
—
6
14
(3002256) Pathology report gross observation
49
266
2.02
4.39
1.3
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
71
437
1.83
4.38
5.0
2.9
mmol/l
2.5
2.5
0.19
64
383
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
41
3.54
4.24
2.9
3.0
e9/l
4.6
4.9
0.17
14
41
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
17
59
3.00
3.97
1.1
1.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
173
1397
1.60
3.64
5.5
5.1
mmol/l
6.6
6.7
0.34
166
1301
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
48
276
1.89
3.63
4.7
3.2
umol/l
13.8
8.0
0.56
40
241
(3026493) Urate [Moles/volume] in Serum or Plasma
89
616
1.64
3.55
2.3
2.9
umol/l
4897.2
8257.1
0.29
79
524
(3008295) Osmolality of Serum or Plasma
10
27
3.80
3.38
2.0
1.1
mosm/kgh2o
279.4
276.7
—
10
19
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
10
27
3.80
3.38
2.4
2.3
pg
34.2
33.1
—
10
27
(3018418) pH of Serum or Plasma
101
730
1.59
3.35
4.1
4.1
ph
7.4
7.4
0.35
25
139
(40765096) Chromosome analysis panel by Banding
6
7
8.72
3.28
1.3
1.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
37
213
1.85
2.80
3.5
2.8
e9/l
65.6
70.8
0.64
32
167
(3010503) CD19 cells [#/volume] in Blood
7
14
5.10
2.74
1.6
1.6
e9/l
0.3
0.2
—
7
14
(3007853) Bacteria identified in Skin by Aerobe culture
43
262
1.75
2.71
1.6
1.7
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
37
216
1.82
2.68
4.4
1.9
nmol/l
366.6
374.8
0.10
37
199
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
74
2.38
2.63
2.1
2.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
127
1006
1.47
2.62
13.9
10.4
e9/l
0.0
0.0
0.61
105
822
(3022217) INR in Platelet poor plasma by Coagulation assay
50
323
1.66
2.55
21.8
25.4
inr
1.4
1.4
—
9
42
(3032080) INR in Blood by Coagulation assay
126
1000
1.46
2.55
6.7
9.8
inr
1.2
1.3
0.79
36
295
(4062490)
8
21
3.89
2.48
2.0
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
74
531
1.53
2.44
3.2
2.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
8
6.34
2.38
1.2
1.5
—
—
—
0
0
(3019225) pH of Specimen
35
209
1.77
2.37
5.8
3.8
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
14
4.35
2.16
2.2
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
98
761
1.44
2.16
3.8
2.4
u/l
64.6
56.1
0.82
93
698
(3021440) Promyelocytes/100 leukocytes in Blood
30
177
1.78
2.12
6.3
4.5
%
0.1
0.1
0.20
12
53
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
186
2077
0.70
2.08
5.9
6.2
mmol/mol
39.6
40.6
0.88
177
1929
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
27
3.02
1.95
2.1
3.0
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
11
46
2.45
1.87
1.3
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
50
349
1.52
1.86
1.4
2.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
17
3.58
1.84
1.2
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
31
193
1.68
1.84
6.2
4.3
%
0.8
1.0
0.21
12
61
(3002179) Metamyelocytes/100 leukocytes in Blood
28
170
1.72
1.82
6.5
4.2
%
0.0
0.4
—
8
40
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
47
2.39
1.80
1.2
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
47
2.39
1.80
1.2
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
15
74
2.08
1.78
3.7
3.1
g/l
0.4
0.2
—
8
29
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
18
3.38
1.75
1.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
18
3.38
1.75
2.3
2.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
65
489
1.43
1.67
7.5
4.9
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
19
3.20
1.67
1.2
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
106
867
1.35
1.65
3.7
3.9
e6/l
96.9
101.9
0.04
72
638
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
197
2149
0.73
1.59
4.2
4.6
mmol/l
1.4
1.5
0.70
188
1960
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
26
2.73
1.59
1.3
2.0
ug/l
19.5
14.3
—
7
26
(3037467) Urinalysis macro (dipstick) panel - Urine
177
1568
1.34
1.58
4.9
4.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
124
1044
1.33
1.58
4.7
4.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
33
2.46
1.55
1.3
3.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
33
219
1.57
1.55
2.1
2.6
u/l
41.8
32.4
0.25
27
181
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
21
2.90
1.51
1.0
1.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
83
666
1.35
1.44
3.1
3.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
93
762
1.33
1.40
3.0
3.3
e6/l
22.4
149.2
0.88
69
597
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
200
2163
0.75
1.39
4.4
4.7
mmol/l
4.6
4.5
0.15
189
1991
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
78
954
0.75
1.36
2.2
2.0
pmol/l
95.2
94.7
0.03
41
499
(3020876) Protein [Mass/time] in 24 hour Urine
5
17
2.97
1.36
1.6
2.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
17
2.97
1.36
1.0
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
47
2.17
1.35
1.3
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
42
2.18
1.35
1.2
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
37
263
1.47
1.29
1.4
1.3
titre
1140.0
485.5
—
8
65
(3028707) Methadone [Presence] in Urine by Screen method
5
18
2.81
1.29
1.2
1.6
—
—
—
0
0
(4024509)
5
18
2.81
1.29
1.4
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
44
2.08
1.28
1.1
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
193
2088
0.77
1.26
3.8
4.1
mmol/l
1.4
1.3
0.97
184
1897
(3027008) Opiates [Presence] in Urine
8
36
2.26
1.25
1.4
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
36
2.26
1.25
1.4
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
36
2.26
1.25
1.4
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
25
2.43
1.25
1.2
2.1
—
—
—
0
0
(3026782) Osmolality of Urine
65
514
1.34
1.24
3.0
3.0
mosm/kgh2o
488.9
554.9
1.69
55
441
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
238
2237
1.37
1.22
21.7
15.8
mg/l
25.3
24.2
0.19
208
1785
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
33
0.00
1.17
0.0
1.1
—
6.1
—
0
15
(3004588) Protein electrophoresis panel - Serum or Plasma
24
160
1.55
1.13
1.4
2.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
207
2209
0.77
1.12
4.8
5.2
mmol/l
2.7
2.7
0.42
196
2013
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
40
526
0.72
1.11
1.7
1.8
pmol/l
578.4
444.0
0.50
33
430
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
14
81
1.77
1.11
11.5
4.5
mg/l
1.0
1.6
4.70
14
72
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
202
2161
0.78
1.10
4.6
4.8
mmol/l
5.9
6.1
1.29
182
1953
(1761868) Lipid panel - Serum or Plasma
58
720
0.76
1.10
2.5
3.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
32
2.22
1.09
1.0
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
25
172
1.50
1.04
7.0
4.5
%
0.0
0.2
—
9
47
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
22
2.29
1.04
1.0
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
9
48
1.90
1.01
1.4
1.4
mmol/l
69.7
57.1
—
9
41
(3030467) Casts [#/volume] in Urine by Automated count
83
698
1.27
1.00
3.1
3.2
e6/l
0.1
0.4
3.62
61
531
(3016879) Cocaine [Presence] in Urine
7
35
2.02
1.00
1.4
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
49
1.86
0.99
1.1
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
69
568
1.28
0.99
1.3
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
37
278
1.38
0.98
4.9
8.3
mmol/l
1.0
1.2
0.16
29
231
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
23
2.19
0.98
2.0
2.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
23
2.19
0.98
1.2
3.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
0
30
0.00
0.98
0.0
1.1
—
0.2
—
0
6
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
36
1.97
0.97
1.1
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
32
0.00
0.95
0.0
1.1
—
4.1
—
0
15
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
26
184
1.45
0.95
2.6
3.0
ml/min/173m2
55.7
57.5
—
9
85
(3011288) Drugs identified in Urine by Screen method
6
27
2.25
0.94
1.3
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
40
510
0.75
0.92
3.1
3.0
ug/l
1.0
0.8
0.67
29
334
(36660697) Celiac disease serology panel - Serum
9
155
0.57
0.91
1.0
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
102
888
1.23
0.90
3.4
3.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
12
71
1.72
0.90
1.2
1.3
—
5.2
—
0
5
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
42
1.93
0.89
1.1
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
155
1410
1.22
0.89
4.3
3.2
u/l
77.5
50.2
1.35
144
1312
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
30
2.02
0.87
2.0
4.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
45
1.80
0.85
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
31
1.95
0.85
1.5
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
10
57
1.78
0.84
1.2
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
245
2346
1.30
0.83
18.0
10.8
u/l
29.1
25.9
1.86
235
2261
(3011397) Hemoglobin [Presence] in Urine by Test strip
63
525
1.26
0.82
3.5
3.9
—
—
—
0
0
(4010399)
10
163
0.60
0.81
1.6
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
11
66
1.69
0.80
1.1
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
40
498
0.77
0.78
1.8
1.7
nmol/l
1075.8
1197.4
0.45
31
379
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
25
333
0.73
0.77
1.4
1.3
u/ml
56.0
10.6
—
7
123
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
15
219
0.67
0.76
2.3
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
67
1.67
0.76
3.8
1.8
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
24
2.10
0.75
2.2
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
34
265
1.32
0.74
2.6
3.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
125
1129
1.19
0.74
3.6
4.0
estimate
0.0
0.0
0.00
23
211
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
27
351
0.75
0.72
1.3
1.3
iu/ml
37.8
36.2
0.03
11
126
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
26
1.94
0.71
1.0
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
49
405
1.25
0.69
2.7
3.1
e6/l
0.4
2.5
4.05
27
236
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
59
1.54
0.69
1.1
1.2
—
—
—
0
0
(4306422)
5
27
1.87
0.68
1.0
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
27
1.87
0.68
1.0
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
77
878
0.83
0.68
4.7
5.0
ug/l
2.8
2.6
0.17
71
782
(3016502) Oxygen saturation in Arterial blood
32
251
1.31
0.68
5.3
8.8
%
95.7
95.3
0.12
32
243
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
49
407
1.25
0.67
1.4
1.9
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
50
594
0.81
0.66
2.2
2.1
mg/l
2.9
3.1
0.24
50
519
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
70
1.59
0.66
1.2
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
62
531
1.21
0.64
2.6
2.6
e6/l
4.5
4.1
0.13
54
468
(21494434) Karyotype in Bone marrow
5
29
1.74
0.64
1.2
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
50
1.62
0.62
1.3
1.9
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
0.0
—
0
5
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
0.2
—
0
6
(4281824)
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
21
0.00
0.60
0.0
4.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
1.4
—
0
6
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
50
424
1.22
0.57
2.7
2.8
e6/l
0.5
1.1
2.36
28
250
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
38
457
0.81
0.57
1.2
1.2
u/ml
0.4
1.5
—
7
108
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
36
1.68
0.57
1.0
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
21
272
0.75
0.56
1.7
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
8
123
0.64
0.56
1.0
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
37
1.63
0.56
1.3
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
57
492
1.20
0.55
4.6
4.1
ng/l
570.0
178.3
0.32
49
403
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
15
108
1.41
0.54
2.8
9.0
%
1.1
1.6
1.82
15
100
(3052851) Hemolysis interference index of Serum or Plasma
11
74
1.51
0.54
3.5
3.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
28
224
1.28
0.53
1.8
2.3
ug/l
5.6
6.6
0.19
22
199
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
39
1.55
0.53
1.2
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
39
1.55
0.53
1.0
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
62
705
0.85
0.53
3.9
4.4
%
24.7
21.7
0.77
38
337
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
193
2020
0.86
0.52
5.5
4.6
mu/l
1.8
2.0
1.90
180
1809
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
9
65
1.40
0.51
1.1
2.2
g/l
0.0
0.0
—
9
60
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
47
1.50
0.48
1.0
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
37
312
1.21
0.46
6.2
6.3
mmol/l
1.1
1.1
0.02
32
291
(3021601) Nitrite [Presence] in Urine by Test strip
122
1133
1.13
0.46
4.9
5.4
estimate
0.0
0.0
0.00
22
209
(3012516) Albumin [Mass/volume] in Urine
62
696
0.86
0.45
3.6
3.2
mg/l
109.1
340.2
0.77
41
445
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
95
1.39
0.44
1.2
1.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
24
194
1.26
0.43
2.9
3.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
66
735
0.87
0.43
4.2
4.0
mg/mmol
16.3
10.2
0.38
42
460
(3022313) Gas panel - Capillary blood
17
131
1.32
0.43
4.8
6.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
57
1.41
0.42
1.3
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
123
1148
1.13
0.42
3.7
4.0
estimate
0.0
0.0
0.00
23
202
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
161
0.73
0.42
1.4
1.8
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
10
70
1.44
0.42
2.5
12.8
mmol/l
1.0
1.3
—
10
62
(3044290) Cell count panel - Cerebral spinal fluid
5
33
1.52
0.41
2.6
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(4027681)
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(4094501)
8
59
1.37
0.41
1.3
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
178
1700
1.12
0.41
4.6
4.0
mm/h
12.2
12.9
0.27
164
1547
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.6
—
1.0
—
0
17
(3017569) Oxygen content in Arterial blood
0
17
0.00
0.41
0.0
5.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.1
—
35.5
—
0
12
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
102
0.68
0.40
1.4
1.4
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.0
—
534.6
—
0
9
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.0
—
287.4
—
0
9
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
0.1
—
0
8
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
40.5
—
0
9
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
105
0.66
0.40
1.1
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
117
1249
0.89
0.39
2.4
2.8
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
9
66
1.38
0.39
1.1
2.2
g/l
0.0
0.0
—
9
60
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
89
1.36
0.38
1.2
2.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
89
1.36
0.38
1.2
2.0
g/l
10.3
10.6
0.08
12
75
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
36
1.40
0.38
1.2
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
49
433
1.16
0.38
3.1
1.4
g/l
2.5
2.6
0.15
32
250
(40761535) Cells panel - Urine sediment
24
198
1.23
0.37
4.2
3.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
54
481
1.15
0.37
2.3
2.1
mg/l
1.4
1.4
0.04
48
385
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
9
71
1.28
0.36
1.1
2.1
g/l
0.0
0.0
—
9
65
(40761511) CBC panel - Blood by Automated count
224
2300
0.88
0.35
17.3
15.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
79
727
1.12
0.34
3.2
3.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
29
248
1.19
0.33
1.1
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
29
248
1.19
0.33
8.8
4.1
mmol/l
2.6
1.9
0.64
21
198
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
172
1652
1.10
0.32
4.8
3.8
pmol/l
14.9
14.9
0.14
160
1466
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
83
1.34
0.32
1.2
1.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
97
0.71
0.31
2.9
2.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
56
1.26
0.29
1.3
4.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
29
252
1.17
0.28
1.0
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
10
76
1.33
0.28
1.6
8.2
u/ml
0.4
0.4
—
5
40
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
139
0.78
0.27
2.1
2.7
—
—
—
0
0
(3044889) 12 lead EKG panel
168
1620
1.09
0.27
4.1
4.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
66
1.22
0.27
1.1
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
211
2056
1.10
0.26
21.5
15.0
ml/min/173m2
80.8
76.8
2.33
185
1689
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
72
0.69
0.26
1.2
2.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
6
81
0.74
0.24
1.3
3.2
mmol/l
4.2
3.9
—
6
71
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
6
81
0.74
0.24
1.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
147
0.81
0.24
5.4
4.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
68
727
0.92
0.23
3.4
3.1
mmol/l
7.9
7.4
0.35
52
596
(3019550) Sodium [Moles/volume] in Serum or Plasma
236
2317
1.10
0.23
23.8
18.7
mmol/l
139.4
139.7
0.96
229
2254
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.4
2.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
42
1.19
0.21
1.2
1.4
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
11
0.00
0.21
0.0
1.5
—
1.3
—
0
6
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
9.5
—
0
11
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.7
—
6.7
—
0
5
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
27.6
—
0
10
(3013637) Mi-2 Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
202
1973
1.08
0.21
22.7
17.1
%
39.1
39.3
0.11
144
1354
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
15
126
1.20
0.21
8.1
12.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3012544) pH of Venous blood
29
259
1.13
0.21
8.7
4.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
17
145
1.18
0.21
1.5
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
59
632
0.92
0.21
3.2
3.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
43
1.17
0.21
1.4
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.5
—
3.7
—
0
5
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
13
108
1.21
0.20
3.2
9.1
%
0.8
0.9
0.36
13
101
(44813793)
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3000492) Spirometry study
17
196
0.86
0.19
1.7
1.6
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
28
252
1.12
0.18
9.0
4.0
kpa
5.5
5.7
0.67
28
245
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
62
1.13
0.17
1.3
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
65
615
1.07
0.16
3.7
4.4
estimate
0.0
0.0
0.50
20
205
(3023103) Potassium [Moles/volume] in Serum or Plasma
236
2327
1.08
0.16
23.8
18.8
mmol/l
4.0
4.0
0.03
228
2261
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
80
1.13
0.15
1.1
1.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
9
81
1.11
0.15
1.4
2.0
ug/l
91.4
294.7
—
9
75
(3019060) Gas panel - Arterial blood
15
171
0.87
0.15
2.0
6.6
—
—
—
0
0
(4034850)
9
82
1.10
0.15
25.1
11.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
160
1.13
0.14
1.3
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
11
94
1.18
0.13
2.5
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
18
161
1.13
0.13
1.4
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
15
169
0.88
0.13
3.9
2.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
32
298
1.08
0.12
1.4
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
114
1.15
0.12
1.4
1.6
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
24
221
1.09
0.11
9.8
3.3
kpa
4.4
4.4
0.06
24
213
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
85
878
0.95
0.11
3.9
4.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
88
908
0.96
0.10
2.5
2.3
nmol/l
80.1
76.3
0.54
81
801
(3003338) MCHC [Mass/volume]
186
1832
1.04
0.10
27.8
20.9
g/l
332.6
332.2
0.28
181
1826
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
45
1.11
0.10
1.0
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
45
1.11
0.10
4.0
2.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
52
498
1.05
0.09
4.2
4.5
kg/l
1.0
1.0
—
6
82
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
47
1.06
0.09
1.2
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
14
126
1.12
0.09
1.4
1.7
—
—
—
0
0
(3039000) Anion gap in Blood
6
56
1.07
0.08
3.0
14.0
mmol/l
9.5
11.4
—
6
50
(3018572) Chloride [Moles/volume] in Blood
6
56
1.07
0.08
3.0
14.0
mmol/l
101.3
105.2
—
6
50
(1761482) Bacteria [#/volume] in Urine by Culture
8
90
0.89
0.07
6.5
5.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8
93
0.86
0.07
1.6
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
13
142
0.91
0.06
2.2
1.4
—
—
—
0
0
(3013512) EKG study
74
722
1.03
0.06
3.5
4.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
245
2435
1.04
0.05
31.6
23.2
e9/l
240.5
243.2
0.23
236
2376
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
131
0.91
0.05
1.1
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
20
212
0.94
0.05
15.6
7.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
31
297
1.05
0.05
1.5
1.8
—
—
—
0
0
(3024731) MCV [Entitic volume]
245
2437
1.04
0.04
31.5
23.1
fl
91.4
91.3
0.15
239
2404
(3026361) Erythrocytes [#/volume] in Blood
245
2438
1.03
0.04
31.6
23.1
e12/l
4.4
4.5
0.18
236
2369
(3035941) MCH [Entitic mass]
245
2438
1.03
0.04
31.5
23.0
pg
30.5
30.4
0.46
239
2404
(3010813) Leukocytes [#/volume] in Blood
245
2438
1.03
0.04
31.7
23.2
e9/l
7.1
6.8
0.67
237
2367
(40768797) Stomach Pathology biopsy report
32
309
1.04
0.04
1.2
1.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
245
2439
1.03
0.03
31.9
23.3
g/l
134.0
134.3
0.14
239
2401
(40768443) Skin Pathology biopsy report
10
92
1.09
0.03
1.3
1.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
22
229
0.96
0.03
5.4
9.4
g/l
129.2
121.9
1.01
22
222
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
78
770
1.02
0.02
3.4
3.4
ng/l
1118.2
1454.2
0.64
66
654
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
73
722
1.01
0.01
2.7
2.1
u/l
131.0
210.9
1.59
67
678
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
13
132
0.98
0.00
4.2
2.5
%
1.3
1.3
0.00
13
132
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
18
178
1.01
0.00
1.8
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
32
317
1.01
0.00
1.3
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
28
283
0.99
0.00
8.9
8.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
15
146
1.03
0.00
3.6
2.6
e9/l
4.4
3.8
0.50
15
111
(40768800) Prostate Pathology biopsy report
5
54
0.92
0.00
1.4
1.1
—
—
—
0
0
(4015189)
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
29.9
—
0
6
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.1
—
150.1
—
0
9
(3034426) Prothrombin time (PT)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
9
0.00
0.00
0.0
2.0
—
1.2
—
0
9
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
135.2
—
0
6
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(1002224) Polysomnography panel
7
70
1.00
0.00
1.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
9
0.00
0.00
0.0
2.9
—
13.6
—
0
9
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
63
0.95
0.00
1.2
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
49
1.02
0.00
2.0
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
51
0.98
0.00
1.0
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
77
0.91
0.00
1.1
1.8
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.8
—
59.9
—
0
5
(3040893) Potassium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
4.2
—
4.2
—
0
5
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.0
—
52.6
—
0
5
(3022689) Creatine [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
2.2
—
10948.8
—
0
5
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.4
—
0.6
—
0
5
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
98
980
1.00
0.00
4.1
4.0
ng/l
20.9
50.8
3.48
77
726
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
11.3
—
0
5
(3014051) Protein [Presence] in Urine by Test strip
5
57
0.88
0.00
3.2
2.2
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020891) Body temperature
9
94
0.96
0.00
2.7
4.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
8
0.00
0.00
0.0
1.9
—
1.2
—
0
8
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
69
0.87
0.00
1.7
1.4
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
1.1
—
0
5
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
18.4
—
0
5
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
17.3
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_EYE_ADNEXA – Malignant neoplasm of eye and adnexa
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).